Form 4: Hims & Hers Health Director Sells 40,000 Shares

David B. Wells, a director at Hims & Hers Health, Inc., sold 40,000 shares of Class A Common Stock at an average price of $29.9896 on November 13, 2024.

Summary

• David B. Wells, a director of Hims & Hers Health, Inc., sold 40,000 shares of Class A Common Stock on November 13, 2024.
• The shares were sold at a weighted average price of $29.9896.
• The sale was executed through a broker, and the price ranged from $29.97 to $30.055 per share.
• Following the transaction, Mr. Wells directly owns 156,036 shares of Hims & Hers Health, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing for a stock sale by a director. It is a neutral event and does not indicate positive or negative sentiment.

Industry Context

This is a routine disclosure of a stock sale by a company director, which is common in the public markets. It does not indicate any specific trend in the health technology industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders and are required by the SEC.
• The sale of shares by a director is a common occurrence and does not necessarily indicate a negative outlook for the company.
• Similar filings are made by directors and officers of all publicly traded companies, such as Teladoc Health and GoodRx, when they buy or sell shares.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but it is not necessarily indicative of the company's performance.

Key Dates

Keywords

Hims & Hers Health, insider trading, stock sale, Form 4, David B. Wells, director, equity securities